$GCTK
GlucoTrack Inc

2022 Q3 Form 10-Q Financial Statement

#000149315222022643 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $495.0K $654.0K $633.0K
YoY Change 54.69% 18.48% 7.84%
% of Gross Profit
Research & Development $434.0K $469.0K $460.0K
YoY Change -2.91% 46.11% 48.87%
% of Gross Profit
Depreciation & Amortization $5.000K $5.000K $9.000K
YoY Change -54.55% -50.0% -25.0%
% of Gross Profit
Operating Expenses $929.0K $1.123M $1.093M
YoY Change 21.12% 28.64% 21.99%
Operating Profit -$929.0K -$1.123M -$1.093M
YoY Change 21.12% 28.64%
Interest Expense $2.000K -$4.000K $0.00
YoY Change -77.78% -120.0% -100.0%
% of Operating Profit
Other Income/Expense, Net -$1.000K
YoY Change -97.83%
Pretax Income -$928.0K -$1.127M -$1.093M
YoY Change 15.42% 32.12% 20.91%
Income Tax
% Of Pretax Income
Net Earnings -$928.0K -$1.127M -$1.093M
YoY Change 15.42% 32.12% 20.91%
Net Earnings / Revenue
Basic Earnings Per Share -$0.06 -$0.07 -$0.07
Diluted Earnings Per Share -$0.06 -$0.07 -$70.69K
COMMON SHARES
Basic Shares Outstanding 15.47M shares 15.47M shares 15.46M shares
Diluted Shares Outstanding 15.47M shares 15.47M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.241M $3.854M $4.789M
YoY Change -53.7% -51.17% -46.11%
Cash & Equivalents $3.241M $3.854M $4.789M
Short-Term Investments
Other Short-Term Assets $187.0K $370.0K $442.0K
YoY Change 187.69% 436.23% 882.22%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.428M $4.224M $5.231M
YoY Change -53.79% -49.18% -43.63%
LONG-TERM ASSETS
Property, Plant & Equipment $44.00K $49.00K $78.00K
YoY Change -67.65% -77.42% -72.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $39.00K $44.00K $50.00K
YoY Change -50.0% -43.59% -24.24%
Total Long-Term Assets $83.00K $93.00K $128.0K
YoY Change -61.21% -68.47% -63.22%
TOTAL ASSETS
Total Short-Term Assets $3.428M $4.224M $5.231M
Total Long-Term Assets $83.00K $93.00K $128.0K
Total Assets $3.511M $4.317M $5.359M
YoY Change -54.0% -49.84% -44.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $713.0K $617.0K $590.0K
YoY Change 10.54% -15.48% -14.99%
Accrued Expenses $0.00 $0.00 $12.00K
YoY Change -100.0% -100.0% -89.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $965.0K $935.0K $916.0K
YoY Change 7.46% -13.82% -26.6%
LONG-TERM LIABILITIES
Long-Term Debt $191.0K $192.0K $206.0K
YoY Change -4.98% -2.54% 7.29%
Other Long-Term Liabilities $0.00 $0.00 $6.000K
YoY Change -100.0% -100.0% -84.62%
Total Long-Term Liabilities $191.0K $192.0K $212.0K
YoY Change -18.38% -18.64% -8.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $965.0K $935.0K $916.0K
Total Long-Term Liabilities $191.0K $192.0K $212.0K
Total Liabilities $1.156M $1.127M $1.128M
YoY Change 2.12% -14.69% -23.73%
SHAREHOLDERS EQUITY
Retained Earnings -$100.6M -$99.69M
YoY Change
Common Stock $102.9M $102.8M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.355M $3.190M $4.231M
YoY Change
Total Liabilities & Shareholders Equity $3.511M $4.317M $5.359M
YoY Change -54.0% -49.84% -44.34%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$928.0K -$1.127M -$1.093M
YoY Change 15.42% 32.12% 20.91%
Depreciation, Depletion And Amortization $5.000K $5.000K $9.000K
YoY Change -54.55% -50.0% -25.0%
Cash From Operating Activities -$608.0K -$916.0K -$1.265M
YoY Change -31.99% -5.47% 35.58%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$4.000K
YoY Change 300.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$4.000K
YoY Change -233.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -608.0K -916.0K -1.265M
Cash From Investing Activities 0.000 -4.000K
Cash From Financing Activities
Net Change In Cash -608.0K -920.0K -1.265M
YoY Change -31.99% -4.76% 35.58%
FREE CASH FLOW
Cash From Operating Activities -$608.0K -$916.0K -$1.265M
Capital Expenditures $0.00 -$4.000K
Free Cash Flow -$608.0K -$912.0K
YoY Change -31.99% -5.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
GCTK
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Central Index Key
EntityCentralIndexKey
0001506983
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
usd
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41141
dei Entity Registrant Name
EntityRegistrantName
GLUCOTRACK, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0668934
dei Entity Address Address Line1
EntityAddressAddressLine1
301 Rte 17N
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800
dei Entity Address City Or Town
EntityAddressCityOrTown
Rutherford
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07070
dei City Area Code
CityAreaCode
972
dei Local Phone Number
LocalPhoneNumber
(8) 675-7878
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15473262 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3854000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6062000 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
370000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
43000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
4224000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
6105000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
40000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
69000 usd
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
44000 usd
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
51000 usd
CY2022Q2 us-gaap Assets
Assets
4317000 usd
CY2021Q4 us-gaap Assets
Assets
6265000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
617000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
631000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
23000 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
318000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
229000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
935000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
883000 usd
CY2022Q2 us-gaap Due To Officers Or Stockholders Noncurrent
DueToOfficersOrStockholdersNoncurrent
192000 usd
CY2021Q4 us-gaap Due To Officers Or Stockholders Noncurrent
DueToOfficersOrStockholdersNoncurrent
210000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17000 usd
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
192000 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
227000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
1127000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
1110000 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15473262 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15473262 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15452285 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15452285 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
15000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
15000 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
15000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
15000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
102821000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
102612000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
31000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6000 usd
CY2022Q2 GCTK Receipts On Account Of Shares
ReceiptsOnAccountOfShares
9000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-99686000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97466000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3190000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
5155000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4317000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6265000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
929000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
630000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
469000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
321000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
23000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1287000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1116000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
654000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
552000 usd
us-gaap Operating Expenses
OperatingExpenses
2216000 usd
us-gaap Operating Expenses
OperatingExpenses
1769000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1123000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
873000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2216000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1769000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1123000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-873000 usd
GCTK Financing Income Expense Net
FinancingIncomeExpenseNet
-4000 usd
GCTK Financing Income Expense Net
FinancingIncomeExpenseNet
12000 usd
CY2022Q2 GCTK Financing Income Expense Net
FinancingIncomeExpenseNet
-4000 usd
CY2021Q2 GCTK Financing Income Expense Net
FinancingIncomeExpenseNet
20000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2220000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1757000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1127000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-853000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
37000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
30000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-29000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2183000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1764000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1097000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-882000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15465692 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15447490 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15473813 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15448212 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
8982000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1757000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
58000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
7286000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
8149000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-853000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-29000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
7286000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
5155000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2220000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
37000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
20000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
198000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3190000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4231000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1127000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
30000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
9000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
9000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
47000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3190000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2220000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1757000 usd
us-gaap Depreciation
Depreciation
14000 usd
us-gaap Depreciation
Depreciation
22000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
198000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
58000 usd
GCTK Issuance Of Restricted Shares As Compensation To Board Of Directors
IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors
20000 usd
GCTK Issuance Of Restricted Shares As Compensation To Board Of Directors
IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors
10000 usd
GCTK Linkage Difference On Principal Of Loans From Stockholders
LinkageDifferenceOnPrincipalOfLoansFromStockholders
6000 usd
GCTK Linkage Difference On Principal Of Loans From Stockholders
LinkageDifferenceOnPrincipalOfLoansFromStockholders
2000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
331000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
13000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
18000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-131000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
114000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-90000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2181000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1902000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-30000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-16000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2215000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1915000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6113000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9885000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3898000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7970000 usd
CY2021Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 13
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-99686000 usd
CY2022Q2 us-gaap Cash
Cash
3854000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6512638 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3854000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6360344 shares
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zwKjO8s16uMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B. </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zx1rBaOb3we8">Use of estimates in the preparation of financial statements</span></b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these consolidated interim condensed financial statements, the most significant estimates and assumptions relate to the going concern assumptions.</span></td></tr> </table> <p style="margin: 0"> </p>
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6062000 usd

Files In Submission

Name View Source Status
0001493152-22-022643-index-headers.html Edgar Link pending
0001493152-22-022643-index.html Edgar Link pending
0001493152-22-022643.txt Edgar Link pending
0001493152-22-022643-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q.htm Edgar Link pending
gctk-20220630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
gctk-20220630_def.xml Edgar Link unprocessable
gctk-20220630_pre.xml Edgar Link unprocessable
gctk-20220630_lab.xml Edgar Link unprocessable
gctk-20220630_cal.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed